Innovating Primary Packaging: The New SCHOTT TOPPAC® Cartridge
Information
SCHOTT Pharma proudly introduces a new polymer container for the evolving demands of biologic therapies to its trusted SCHOTT TOPPAC® family. The SCHOTT TOPPAC® cartridge platform, made from advanced Cyclic Olefin Copolymer (COC), delivers outstanding drug stability and safety. Its inert surface, low extractables and leachables, and cross-linked silicone oil minimize protein adsorption, making it ideal for sensitive biologics.
This ready-to-use (RTU) polymer cartridge is compatible with existing devices and designed for seamless integration into standard fill-and-finish lines. It offers tight dimensional tolerances, high break resistance, and reliable performance, even for high-viscosity formulations.
The cartridge adds flexibility to a trusted platform by sharing the same proven material and composition as SCHOTT TOPPAC® syringes, used for over 80 approved drugs across 100+ regulated markets. Its polymer design supports low CO₂ emissions and water-free production, making it an innovative, scalable, and eco-conscious solution for the future of biologic therapies.
